Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by R. N. Pillai
CHFR Protein Expression Predicts Outcomes to Taxane-Based First Line Therapy in Metastatic NSCLC
Clinical Cancer Research
Cancer Research
Oncology
Distributions With Complete Monotone Derivative and Geometric Infinite Divisibility
Advances in Applied Probability
Applied Mathematics
Statistics
Probability
Related publications
MA10.08 Choice of Taxane and Outcomes in the KEYNOTE-407 Study of Pembrolizumab Plus Chemotherapy for Metastatic Squamous NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Osimertinib as First-Line Therapy in Advanced NSCLC: A Profile of Its Use
Drugs and Therapy Perspectives
Pharmacology
First-Line Osimertinib in Patients With Treatment-Naive Somatic or Germline EGFR T790M–Mutant Metastatic NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P3.01-65 First-Line Radical Local Therapy May Provide Additional Survival Gain for Patients With EGFR-Mutant Metastatic NSCLC Receiving TKIs
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Xeloda as First-Line Therapy of Metastatic Colorectal Cancer-Our Experience
Archive of Oncology
Oncology
Hematology
First-Line Therapy for Metastatic Colorectal Cancer: Current Perspectives and Future Directions
Asia-Pacific Journal of Clinical Oncology
Medicine
Oncology
NSCLC - First-Line-Chemotherapie Häufiger Als Erwartet
Pneumologie
Medicine
Pulmonary
Respiratory Medicine
Cost-Effectiveness of First-Line Therapy for Advanced Non-Small Cell Lung Cancer (Nsclc)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pcn34 - Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Non-Squamous NSCLC – A Network Meta-Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental